Skip to main content
VKTX logo

Viking Therapeutics, Inc.

VKTXNASDAQHealthcareBiotechnology

$25.17Today:- (-)1Y −18.38%

As of Oct 16, 2026 close

Market cap
$3.18B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$25.28$43.15
Volume (live)
-
Avg. volume (3M)
7.37M

Viking Therapeutics, Inc. (VKTX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Viking Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 24 professional research analysts

Consensus Rating

Buy
Based on 24 unique analysts
(36 total ratings in last 90 days)
Very High Confidence20.0:1 Buy/Sell

Average Price Target

$92.18
+266.23% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest VKTX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Edward Nash
Canaccord Genuity
BuyMaintains
$114.00
Unknown Analyst
UBS
BuyInitiates
$94.00
Joseph Pantginis
HC Wainwright
BuyReiterates
$102.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Michael Ulz
Morgan Stanley
BuyReiterates
$95.00
Edward Nash
Canaccord Genuity
BuyMaintains
$114.00
Gregory Renza
Truist
BuyMaintains
$87.00 → $85.00
Naz Rahman
Maxim
BuyReiterates
$70.00
Michael Ulz
Morgan Stanley
BuyReiterates
$95.00
Naz Rahman
Maxim
BuyReiterates
$70.00
Joseph Pantginis
HC Wainwright
BuyReiterates
$102.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Unknown Analyst
Leerink Partners
BuyReiterates
$118.00
Naz Rahman
Maxim
BuyReiterates
$70.00
Roger Song
Jefferies
BuyMaintains
$101.00
Daniel Brims
Lake Street
BuyReiterates
$89.00
Richard Law CFA
Goldman Sachs
HoldMaintains
$35.00 → $38.00
Edward Nash
Canaccord Genuity
BuyReiterates
$114.00
Annabel Samimy
Stifel Nicolaus
BuyReiterates
$30.00 → $95.00
Jeet Mukherjee
BTIG
BuyReiterates
$125.00
William Wood
B Riley
BuyReiterates
$85.00
Jeet Mukherjee
BTIG
BuyReiterates
$125.00
Joseph Pantginis
HC Wainwright
BuyMaintains
$102.00
Annabel Samimy
Stifel Nicolaus
BuyReiterates
$30.00 → $95.00
Michael Ulz
Morgan Stanley
BuyReiterates
$95.00
Richard Law CFA
Goldman Sachs
HoldMaintains
$35.00 → $38.00
Andy Hsieh
William Blair
BuyReiterates
-
Jay Olson
Oppenheimer
BuyInitiates Coverage
$100.00 → $120.00
Sundeep Ganoria
Zacks Equity Research
HoldInitiates Coverage
-
Steven Seedhouse
Cantor Fitzgerald
BuyMaintains
$100.00
Hardik Parikh
JP Morgan
BuyMaintains
$75.00 → $65.00
Edmund Ingham
Forbes
HoldInitiates Coverage
-
Biren Amin
Piper Sandler
BuyMaintains
$71.00
Deepanwita Sarkar Saha
Zacks Equity Research
BuyInitiates Coverage
-
Druckenmiller
Hot Copper
BuyInitiates Coverage
-
Ahan Chakraborty
Zacks Equity Research
SellInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 15, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for VKTX?

The analyst consensus rating for VKTX is Buy, based on the latest ratings from 24 analysts over the last 90 days.

What is the average price target for VKTX?

The average 12-month price target for VKTX is $92.18, representing an upside of 266.2% from the Oct 16, 2026 close of $25.17.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.